Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: Influence of the mechanism of nitric oxide generation

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 2, 1999, Pages 135-139

  Homer, Kerry L ^a   Fiore, Steven A ^a   Wanstall, Janet C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SPERMINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PULMONARY ARTERY; RAT; VASODILATATION;

EID: 0033058689     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772240     Document Type: Article

References (17)

1. Bolotina, V., Najibi, S., Palacino, J. J., Pagano, P. J., Cohen, R. A. (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853
2. Brunner, F., Schmidt, K., Nielsen, E. B., Mayer, B. (1995) Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther. 277: 48-53
3. Feelisch, M., Stamler, J. S. (1996) Donors of nitrogen oxides. In: Feelisch, M., Stamler, J. (eds) Methods in Nitric Oxide Research, John Wiley and Sons, Chichester, pp 71-115
4. Garthwaite, J., Southam, E., Boulton, C. L., Nielsen, E. B., Schmidt, K., Mayer, B. (1995) Potent and selective inhibition of nitric oxide sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48: 184-188
5. Homer, K. L., Wanstall, J. C. (1998) In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries. Eur. J. Pharmacol. 356: 49-57
6. Hussain, A., Marks, G., Brien, J., Nakatsu, K. (1997) The soluble guanylyl cyclase inhibitor 1/H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can. J. Physiol. Pharmacol. 75: 1034-1037
7. Moro, M., Russell, R., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V., Radomski, M., Moncado, S. (1995) cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl Acad. Sci. USA 93: 1480-1485
8. Murad, F. (1994) Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction pathway. Adv. Pharmacol. 26: 19-33
9. Onoue, H., Katusic, Z. S. (1998) The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide. Brain Res. 785: 107-113
10. Plane, F., Hurrell, A., Jeremy, J., Garland, C. (1996) Evidence that potassium channels make a major contribution to SIN-1 evoked relaxation of rat isolated mesenteric artery. Br. J. Pharmacol. 119: 1557-1562
11. Plane, F., Wiley, K. E., Jeremy, J., Cohen, R. A., Garland, C. (1998) Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide donors in the rabbit isolated carotid artery. Br. J. Pharmacol. 123: 1351-1358
12. Schmidt, H. W., Siebe, J., Clement, B., Feelisch, M. (1998) 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) is not a selective inhibitor of soluble guanylyl cyclase: interference with NO-synthase and nitrovasodilator biotransformation. Br. J. Pharmacol. 123: 6P
13. Schrammel, A., Behrends, S., Schmidt, K., Koesling, D., Mayer, B. (1996) Characterisation of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50: 1-5
14. van der Zypp, A., Majewski, H. (1998) Effect of cGMP inhibitors on the actions of nitrodilators in rat aorta. Clin. Exp. Pharmacol. Physiol. 25: 38-43
15. Wanstall, J. C., Homer, K. L. (1998) Inhibition by ODQ (soluble guanylate cyclase inhibitor) of pulmonary vaso-relaxant responses to nitric oxide donors depends on the site of nitric oxide generation (intra- or extracellular). Naunyn Schmiedebergs Arch. Pharmacol. 358 (Suppl. 1): R218
16. Wanstall, J. C., Kaye, J. A., Gambino, A. (1997) The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats. Br. J. Pharmacol. 121: 280-286
17. Ca channels antagonizes NO-induced relaxation in pulmonary artery. Am. J. Physiol. 272: H904-H912